Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular

Rafaela Soler1, Esther Rodríguez, Lorenzo Monserrat

  • 1Department of Radiology, Complejo Hospitalario Universitario Juan Canalejo, La Coruña, Spain. rafaelasoler@telefonica.net

Insights

Delayed myocardial enhancement is common in hypertrophic cardiomyopathy (HCM), often linked to perfusion defects and reduced contractile function. These findings suggest potential roles in risk stratification for HCM patients.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac MRI
  • Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young adults.
  • Cardiac MRI (CMR) is crucial for diagnosing and characterizing HCM.
  • Understanding the relationship between different CMR findings is essential for patient management.

Purpose of the Study:

  • To investigate the associations between myocardial delayed enhancement (MDE), first-pass perfusion (FPP), and contractile function in HCM patients.
  • To determine the prevalence and distribution of MDE in HCM.
  • To explore the clinical significance of these CMR parameters.

Main Methods:

  • Prospective CMR examination of 53 HCM patients using a 1.5-T MR unit.
  • Assessment of global left ventricular function, wall thickness, and mass.
  • Myocardial tissue tagging for contractile function evaluation.
  • T1-weighted sequences for FPP and MDE assessment.

Main Results:

  • MDE was observed in 56.6% of patients, predominantly in hypertrophic segments, but also in normal-thickness segments.
  • FPP defects at rest occurred in 30.1% of patients, correlating with reduced stroke volume and cardiac output.
  • Hypokinetic segments were significantly thicker and associated with MDE.

Conclusions:

  • MDE is prevalent in HCM, occurring in both hypertrophic and normal-thickness segments.
  • Resting FPP defects and impaired contractile function are associated with MDE.
  • Further research is needed to establish the role of MDE, FPP, and myocardial tagging in HCM risk stratification.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...